These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 9441202)

  • 1. Richard Klausner: NCI's multifaceted cancer fighter.
    Larkin M
    Lancet; 1997 Dec; 350(9093):1756. PubMed ID: 9441202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the study of von Hippel-Lindau syndrome].
    Chen F; Wu M
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):236-8. PubMed ID: 9596966
    [No Abstract]   [Full Text] [Related]  

  • 3. The big three. NCI's Richard Klausner.
    Marshall E
    Science; 2001 Jun; 292(5524):1990. PubMed ID: 11408637
    [No Abstract]   [Full Text] [Related]  

  • 4. A PCR generated BsaJ I RFLP in the promoter of the von Hippel-Lindau disease (VHL) tumour suppressor gene.
    Geil L; Semenova E; Lerman MI; Kuzmin I
    Mol Cell Probes; 1998 Oct; 12(5):343-4. PubMed ID: 9778462
    [No Abstract]   [Full Text] [Related]  

  • 5. [VHL gene and TSC 2 gene].
    Hino O
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1386-91. PubMed ID: 9309130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
    Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer. Many vessels, faulty gene.
    Kaelin WG
    Nature; 1999 May; 399(6733):203-4. PubMed ID: 10353237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hippel-Lindau syndrome. Clinical and genetic aspects of angiomatosis retinae].
    Brauch H
    Klin Monbl Augenheilkd; 1997 Mar; 210(3):aA1. PubMed ID: 9206740
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
    Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
    Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
    Martin R; Hockey A; Walpole I; Goldblatt J
    Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCI's Klausner on challenges, solutions. Interview by Hugh McIntosh.
    Klausner R
    J Natl Cancer Inst; 1996 May; 88(10):634-7. PubMed ID: 8627637
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxygen sensing: "hydroxy" translates "oxy".
    Wenger RH; Bauer C
    News Physiol Sci; 2001 Aug; 16():195-6. PubMed ID: 11479372
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer prevention NCI's primary goal.
    Devita VT
    US Med; 1983 Jan; 19(2):77-8. PubMed ID: 10259324
    [No Abstract]   [Full Text] [Related]  

  • 15. The Klausner revolution.
    Marshall E
    Science; 1996 Sep; 273(5280):1328-9, 1331. PubMed ID: 8801625
    [No Abstract]   [Full Text] [Related]  

  • 16. Klausner follows own advice at NCI.
    Marshall E
    Science; 1995 Aug; 269(5226):912-3. PubMed ID: 7638609
    [No Abstract]   [Full Text] [Related]  

  • 17. National Cancer Institute. Klausner quits NCI to head new institute.
    Marshall E
    Science; 2001 Sep; 293(5537):1967. PubMed ID: 11557849
    [No Abstract]   [Full Text] [Related]  

  • 18. Collaboration to play key role in NCI's future, director says. Interview by Katherine Arnold.
    von Eschenbach A
    J Natl Cancer Inst; 2002 Jun; 94(11):790-2. PubMed ID: 12048262
    [No Abstract]   [Full Text] [Related]  

  • 19. Researcher dedicated to tumour-suppressing genes.
    Ahuja CS
    CMAJ; 2017 Oct; 189(43):E1346-E1347. PubMed ID: 29084764
    [No Abstract]   [Full Text] [Related]  

  • 20. The National Cancer Program.
    Wujcik D; Fraser MC
    Semin Oncol Nurs; 2000 Feb; 16(1):65-75. PubMed ID: 10701242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.